Archive

French R&D Tax Credit Accreditation

Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it has been recognised by the French Ministry of…

Final Results for the year ended 30 June 2012

Chairman’s Statement   Summary of Results in the year ended 30 June 2012   Fundraising in April 2012 generated cash of £555,000 before issue expenses.

PKUK Meeting 2012 (Update)

Further to the announcement that a poster will be shown at the PKUK 2012 meeting, Dr Eric Fernandez will give a talk at the conference…

New US Business Development Consultant

Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that Dr. David Jobes will be joining the company as…

PKUK 2012 meeting

Dr Frances Brightman has been accepted for a poster presentation at PKUK 2012 meeting. Frances will show an update on the anti cancer drug combination…

5th International Systems Radiation Biology Workshop (Oxford)

Physiomics will present on “Modelling the responses of populations of cancer cells to therapeutic radiation exposure”, on 5th September at the 5th International Systems Radiation…

Workshop on 27th November 2012 at Le Meridien Park Hotel (Frankfurt)

Physiomics will present a workshop on “Applications of Physiomics’ Virtual Tumour to optimize the outcomes of xenograft experiments”, on 27th November at the 4th PK/PD…

New Agreement to optimise oncology combination with top five pharma company

Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it has signed a new agreement with a top…

New position: Principal Biosimulation Scientist

Physiomics is an AIM – listed Oxford-based systems biology company specialised in computational modelling of complex biological systems. Our Virtual Tumour technology is used by…

Completion of Placing

The Company announces that it has raised £555,000 from the issue of 370,000,000 new ordinary shares of 0.04p each (“Ordinary Shares”) at a price of…